On March 3, 2023, CytoDyn Inc. closed the transaction. The company has now received binding subscription agreements to purchase 21.3 million units at a total purchase price of $0.23 per unit for the gross proceeds of $4,899,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1845 USD | +11.82% | +27.59% | -5.13% |
15/04 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
05/03 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-5.13% | 16Cr | |
+7.77% | 11TCr | |
+10.39% | 11TCr | |
+0.41% | 2.23TCr | |
-11.99% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.22% | 1.72TCr | |
+6.52% | 1.43TCr | |
+36.22% | 1.25TCr |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. announced that it has received $4.899 million in funding